Get the Stockscreener App
2.185
3.74%
-0.085
Aytu Biopharma Inc stock is traded at $2.185, with a volume of 59,627.
It is down -3.74% in the last 24 hours and up +15.00% over the past month.
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.
See More
Previous Close:
$2.27
Open:
$2.24
24h Volume:
59,627
Relative Volume:
0.32
Market Cap:
$19.61M
Revenue:
$66.38M
Net Income/Loss:
$-14.18M
P/E Ratio:
-0.7783
EPS:
-2.8074
Net Cash Flow:
$-5.17M
1W Performance:
-1.13%
1M Performance:
+15.00%
6M Performance:
+66.81%
1Y Performance:
+12.77%
1-Day Range:
$2.12
$2.28
1-Week Range:
$2.12
$2.31
52-Week Range:
$0.95
$2.82
Aytu Biopharma Inc Stock (AYTU) Company Profile
Name
Aytu Biopharma Inc
Sector
Phone
(720) 437-6580
Address
7900 E. UNION AVENUE, DENVER
Compare AYTU with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AYTU
Aytu Biopharma Inc
|
2.185 | 23.13M | 66.38M | -14.18M | -5.17M | -2.8074 |
|
ZTS
Zoetis Inc
|
144.38 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.43 | 42.46B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.385 | 41.28B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.49 | 23.49B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
436.34 | 19.18B | 3.08B | 1.24B | 1.07B | 25.61 |
Aytu Biopharma Inc Stock (AYTU) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-01-25 | Initiated | Lake Street | Buy |
| Jun-30-25 | Initiated | Ascendiant Capital Markets | Buy |
| Mar-30-21 | Initiated | Cantor Fitzgerald | Overweight |
| May-29-20 | Initiated | H.C. Wainwright | Buy |
Aytu Biopharma Inc Stock (AYTU) Latest News
Regression analysis insights on Aytu BioPharma Inc. performanceTrade Signal Summary & Safe Entry Momentum Stock Tips - newser.com
What MACD signals say about Aytu BioPharma Inc.July 2025 Technicals & Fast Exit and Entry Trade Guides - newser.com
Will Aytu BioPharma Inc. (AY20) stock profit from fiscal stimulus2025 Market Sentiment & Safe Entry Point Alerts - newser.com
Understanding Aytu BioPharma Inc.’s price movementJuly 2025 Summary & Real-Time Volume Analysis Alerts - newser.com
Will Aytu BioPharma Inc. stock remain a Wall Street favorite2025 Market Sentiment & Safe Entry Point Alerts - newser.com
Relative strength of Aytu BioPharma Inc. in sector analysis2025 Pullback Review & Expert Approved Momentum Ideas - newser.com
How Aytu BioPharma Inc. (AY20) stock moves in volatile trading sessionsEarnings Risk Report & Low Risk Profit Maximizing Plans - newser.com
Why Aytu BioPharma Inc. stock remains resilientQuarterly Portfolio Review & Risk Controlled Daily Trade Plans - newser.com
Will Aytu BioPharma Inc. stock attract more institutional investors2025 Key Highlights & Weekly High Return Stock Opportunities - newser.com
Applying Elliott Wave Theory to Aytu BioPharma Inc.Quarterly Portfolio Report & Breakout Confirmation Trade Signals - newser.com
Real time social sentiment graph for Aytu BioPharma Inc.Weekly Gains Summary & Scalable Portfolio Growth Methods - newser.com
Can Aytu BioPharma Inc. (AY20) stock deliver consistent EPS growthJuly 2025 Catalysts & Real-Time Market Trend Scan - newser.com
How to interpret RSI for Aytu BioPharma Inc. stock2025 Price Targets & Free Real-Time Volume Trigger Notifications - newser.com
Will Aytu BioPharma Inc. stock see insider buyingJuly 2025 Recap & Fast Gain Swing Alerts - newser.com
Will Aytu BioPharma Inc. (AY20) stock announce a stock splitQuarterly Portfolio Review & Entry Point Confirmation Signals - newser.com
Published on: 2025-11-01 08:49:06 - newser.com
Published on: 2025-11-01 06:04:31 - newser.com
Aytu BioPharma Inc AY20 Stock Analysis and ForecastOptions Trading Strategies & Free Short-Term Trading Strategies - earlytimes.in
How to escape a deep drawdown in Aytu BioPharma Inc.Weekly Profit Summary & Risk Managed Investment Entry Signals - newser.com
Published on: 2025-10-31 04:46:09 - newser.com
Can Aytu BioPharma Inc. (AY20) stock withstand sector downturnsWeekly Risk Summary & Reliable Volume Spike Trade Alerts - newser.com
Will Aytu BioPharma Inc. (AY20) stock keep high P E multiplesFed Meeting & Weekly High Return Stock Forecasts - newser.com
Aytu Biopharma Inc Stock (AYTU) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.17%
1.30%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):